Sheridan, Wyoming, Oct. 05, 2026 (GLOBE NEWSWIRE) — Kylo Peptides https://kylopeptides.com/[], a U.S.-based supplier of research-use-only peptides, has received a score of 96.7/100 in a Plastic Surgery Key review of 10 research peptide companies. The review compared suppliers on the paperwork a buyer can check before ordering.

Plastic Surgery Key checked each company’s published records between Sept. 10 and 21, 2026. Measured on documentation alone, the review named Kylo its top pick. It found Kylo was the only one of the 10 to publish a lot-specific certificate of analysis (COA) for every batch, test for both purity and identity, and name the testing laboratory on the report.

What the Plastic Surgery Key Review Examined

The review evaluated all 10 suppliers to the same six criteria:

  • Lot-specific COAs
  • Purity and identity testing
  • Independent laboratory documentation
  • Testing depth beyond purity
  • Supplier transparency, including contacts and published policies
  • Research-only positioning across the whole website

Each criterion is something a buyer can confirm before paying. 

Evaluation Snapshot

Category Evaluation
Company reviewed Kylo Peptides
Overall score 96.7/100
Review source Plastic Surgery Key
Review type Research peptide company evaluation (10 suppliers)
Review window Sept. 10 to 21, 2026
Key areas examined Testing, documentation, transparency, supplier information

What Contributed to Kylo Peptides’ 96.7/100 Assessment

The assessment rested on four areas of public evidence, each open to researchers on Kylo’s website before ordering.

#1. COA Transparency

Kylo keeps a public COA library. Each certificate matches the lot number printed on the vial and is available online. If a lot is still in testing, the COA shows as “pending”. Kylo highlighted this wider case in its report on the research peptide verification gap.

#2. Identity and Purity Documentation

Every lot is tested for purity by HPLC-UV against a 99% minimum target, and LC-MS confirms its identity. Kylo publishes the exact figure for each lot. A recent BPC-157 lot, 2604060200, recorded 99.62% purity.

#3. Independent Testing

Kylo names four outside laboratories: Janoshik Analytical, Freedom Diagnostics, Vanguard Laboratory, and OPTIQ Health Labs. Only four of the 10 reviewed suppliers named any testing lab.

#4. Supplier Policies and Information

Kylo lists its legal entity, address, and contacts. Prices appear on every product page, and orders carry a 30-day money-back guarantee.

Why Documentation Was a Key Part of Kylo’s Evaluation

Documentation lets a buyer review the supplier’s claims before paying. Kylo’s documents are lot-specific and publicly searchable on its COA library. They report purity and identity for each batch, and name the methods plus the lab/s that confirmed them. 

Each COA also includes a unique identifier issued by the testing lab, so researchers can cross-check the report directly on the lab’s portal. These records apply to single compounds as well as Kylo’s blends.

Kylo Peptides’ Testing and Laboratory Documentation

Kylo runs multiple assays on every batch, and it documents all results on the published certificate.

Independent Laboratory Reports

Kylo sends batches to its four named ISO/IEC 17025-accredited laboratories and posts their reports in its COA library, a process it follows for both newly launched and older materials. 

Purity and Identity Documentation

  • HPLC-UV purity, with the exact lot figure published
  • LC-MS identity, matching the molecule’s mass to the label
  • ICP-MS screening for lead, arsenic, cadmium, and mercury
  • Sterility under USP <71>, using a 14-day culture
  • Endotoxin under USP <85>
  • Net content and batch consistency

Each result traces back to the lot number on the vial. These results describe the tested material only and do not show suitability for human use.

What the 96.7/100 Score Represents

The 96.7/100 figure is Plastic Surgery Key’s assessment, based on its six criteria around testing, documentation, transparency, and research-use positioning. Researchers can use it as a reference point to review live supplier sites before ordering, since prices, catalogs, and certificates vary between vendors. Current COAs, testing reports, product details, and policies still deserve an independent look.

Kylo Peptides’ Research-Only Positioning

Kylo sells every product for laboratory research only. Its catalog access sits behind a research-use confirmation step. The company makes no treatment, dosing, or health claims for any compound, including combinations such as its Wolverine Stack. 

Kylo describes itself as a chemical supplier, outside the definitions of a compounding pharmacy under Section 503A and an outsourcing facility under Section 503B. Buyers are expected to follow their own laboratory and institutional rules.

Beyond the Score: What Researchers Should Check for Themselves

Check What to look for
COA Lot-specific documentation that matches the vial
Identity LC-MS or equivalent analytical evidence
Purity HPLC results and the stated specification
Testing Independent laboratory documentation with the lab named
Product information Clear vial and product details
Policies Published ordering, shipping, and refund terms
Research positioning Explicit laboratory-research language on every page

Kylo Peptides Expands Transparency for Research Buyers

Kylo synthesizes and lyophilizes its materials in the United States, and in September it strengthened its U.S. fulfillment. Weekday orders ship the same day, and U.S. orders over $150 ship free. Kylo also expanded its research catalog this year, with 100+ new compounds carrying the same lot documentation.

“We post every certificate on the website, so a lab can check our claims before it orders. Every product is listed by lot number, so the results correspond to the vial you buy,” said Nina Jenson, Spokesperson, Kylo Peptides. 

A Third-Party Review Adds Another Reference Point for Supplier Evaluation

Third-party reviews give researchers a second source to verify a supplier’s claims, alongside the COA. However, they are most useful when read alongside test results like purity and identity, since publications set their own criteria and score only what they measured.

On July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee met to consider BPC-157, KPV, TB-500, MOTS-c, and other peptides for the Section 503A Bulks List. The process covers compounding pharmacies. For research-use suppliers, published lot records remain the main evidence a buyer can compare.

Evaluations also shift as products, documentation, and policies change, so any score stays valid only at a single point in time.

About Kylo Peptides

Kylo Peptides is a U.S.-based supplier of research-use-only peptides for academic groups, private laboratories, and research organizations. Process chemists and QC analysts founded it in 2021. Kylo tests every batch across seven assays and publishes a lot-matched COA for each one. Recent additions include the GLOW Peptide Stack and KLOW Peptide Stack.

About Plastic Surgery Key’s Review

Plastic Surgery Key published “Top Research Peptide Companies: 10 Best Peptide Companies Ranked by COA Transparency” in September 2026. It compared 10 suppliers on six documentation criteria and gave Kylo Peptides a score of 96.7/100. 

Final Thoughts

Kylo Peptides’ 96.7/100 assessment from Plastic Surgery Key rests on what the review examined: lot-specific COAs, purity and identity testing, and named laboratories. Researchers can use it as a reference point while checking current COAs, testing records, and supplier policies themselves.

Disclaimer: Kylo Peptides products are for laboratory research use only and are not for human or veterinary use. The FDA has not evaluated these statements. These products are not intended to diagnose, treat, cure, or prevent any disease.


Company Name: Kylo Labs LLC
Address: 30 N Gould St, Ste R, Sheridan, WY 82801 
Phone: +1 350-252-3314 
Email: support@kylopeptides.com
Website: https://kylopeptides.com/ 

Media gallery

About The Author
Kylo Lab LLC